Sandu Pharmaceuticals Q4 Results
- BSE: 524703
- NSE: -
- ISIN: INE751D01014
- Sector: Biotechnology & Drugs
BSE
43.01
4.91 (12.89%)
4.91 (12.89%)Volume36.60 K
Updated: Wed 22 Apr, 2026 | 15:29:30
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Sandu Pharmaceuticals Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 13.77 | 17.89 | -21.64% | 15.18 | -9.29% |
| Depreciation/ Amortization | 0.15 | 0.17 | -21.84% | 0.19 | -20.54% |
| Operating Income | 0.30 | 0.87 | -62.64% | 0.42 | -28.32% |
| Net Income | 0.33 | 0.98 | -41.21% | 0.59 | -45.06% |
| Other Operating Expenses Total | 5.02 | 7.19 | -6.47% | 6.32 | -20.69% |
| Net Income Before Taxes | 0.34 | 0.86 | -57.11% | 0.72 | -52.38% |
| Total Revenue | 14.07 | 18.76 | -23.42% | 15.60 | -9.80% |
| Selling/ General/ Admin Expenses Total | 2.83 | 2.65 | -10.44% | 2.47 | 14.47% |
| Diluted Normalized EPS | 0.33 | 1.01 | -41.36% | 0.61 | -45.16% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.